Authors
Latest:
Pediatric MDS Update with Dr. Inga Hofmann ZhangDr. Inga Hofman Zhang from the University of Wisconsin School of Medicine provides an update on treating MDS in children.
Latest:
Sex-related differences in treatment and outcome in patients with ACSThe AMIS (Acute Myocardial Infarction in Switzerland) Plus prospective cohort study compared treatment and in-hospital outcomes between men and women with acute coronary syndrome (N = 26,452) admitted to Swiss hospitals between 1997 and 2007. The study reached several important conclusions: women had different baseline characteristics than men at admission, were treated with different drug regimens, and were significantly less likely to undergo percutaneous coronary intervention. After adjusting for these differences, researchers found no significant difference in the rates of in-hospital mortality between men and women, except for women aged 51 to 60 years, who were more likely to die in-hospital.
Latest:
Nonfasting triglycerides and ischemic heart disease in men and womenTriglyceride levels are usually measured after the patient has fasted, and then exclude remnant lipoproteins. Except for the first few hours of the morning, individuals are usually in a nonfasting state for most of the day. We investigated whether nonfasting triglyceride levels predicted the risk of myocardial infarction (MI), ischemic heart disease, and death in the general population. Results showed that increased nonfasting triglyceride levels were associated with an increased risk of MI, ischemic heart disease, and death.
Latest:
Early invasive or selective invasive strategies for ACS patientsTreatment of stable patients with acute coronary syndrome (ACS) is controversial. Until recently, large randomized clinical trials had indicated that an "early" invasive strategy with routine cardiac catheterization reduced the likelihood of recurrent cardiovascular events when compared with a more "selective" approach, in which stable patients were referred to cardiac catheterization based on high-risk features on noninvasive stress imaging or because of a failure in initial medical therapy.
Latest:
WhatLatest:
Changes in the Diagnostic Process of Alzheimer Disease: A New Era of Blood-Based ApproachesWhile specialists still debate the diagnostics of impaired cognition, the identification of patients at the earliest stages is beginning to be met through new biomarkers and available assays.
Latest:
The prognostic role of metabolic syndrome after myocardial infarctionWe evaluated the prognostic role of metabolic syndrome after myocardial infarction and found that metabolic syndrome correlated with an increased risk of cardiovascular events and death. The risk of developing diabetes decreased with weight loss in patients with metabolic syndrome. These results indicate that a more aggressive approach to the treatment of patients with metabolic syndrome, particularly with regard to changes in lifestyle, would be beneficial.
Latest:
Intermittent inotropic therapy: A clinician's opinionCan any physician consider using intermittent inotropic therapy in patients with congestive heart failure?
Latest:
The Nurse's Role in Recruitment and Retention of Clinical Trial ParticipantsRecruiting patients to participate in clinical trials is a challenging and time-consuming endeavor, especially when it comes to cancer clinical trials.
Latest:
AJMC Study Looks at the Shaky Foundation of the Patient-centered Medical HomeThe patient-centered medical home has been proposed as a solution to the challenges facing primary care, but there are several concerns over whether this approach is feasible.
Latest:
Lessons Learned from My Doctor-PatientsA doctor writes on his experiences in treating colleagues in his psychiatry practice, and the humility he's gained from it.
Latest:
Case-Based Peer Perspectives in Fabry DiseaseDawn Laney, MS, CGC, CCRC, Assistant Professor and Director, Emory Genetic Clinical Trials Center, talks misdiagnosis in Fabry disease through a case study.
Latest:
Keeping Patients Safe from Methadone Overdose: A Pharmacist's PerspectiveConfusion between methadone and other medications with lookalike names can cause life-threatening errors.
Latest:
Chemotherapy Foundation Symposium OverviewThis year's Chemotherapy FoundationSymposium, entitled
